Using Artificial Intelligence to Learn Optimal Regimen Plan for Alzheimer’s Disease

Mostrar otras versiones (1)

BACKGROUND: Alzheimer’s Disease (AD) is a progressive neurological disorder with no specific curative medications. While only a few medications are approved by FDA (i.e., donepezil, galantamine, rivastigmine, and memantine) to relieve symptoms (e.g., cognitive decline), sophisticated clinical skills...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattarai, Kritib, Das, Trisha, Kim, Yejin, Chen, Yongbin, Dai, Qiying, Li, Xiaoyang, Jiang, Xiaoqian, Zong, Nansu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901063/
https://www.ncbi.nlm.nih.gov/pubmed/36747733
http://dx.doi.org/10.1101/2023.01.26.23285064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901063/
https://www.ncbi.nlm.nih.gov/pubmed/36747733
http://dx.doi.org/10.1101/2023.01.26.23285064

Ejemplares similares